Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products.
Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products for the treatment of bacterial infections.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 23, 2000 | Series B | Fr40M | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Partners Group
|
— | Series B |